BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 3913773)

  • 1. Longterm methotrexate therapy in rheumatoid arthritis: a review.
    Kremer JM
    J Rheumatol Suppl; 1985 Dec; 12 Suppl 12():25-8. PubMed ID: 3913773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short term efficacy of methotrexate in the treatment of rheumatoid arthritis.
    Willkens RF
    J Rheumatol Suppl; 1985 Dec; 12 Suppl 12():21-4. PubMed ID: 3913772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longterm drug therapy for rheumatoid arthritis in seven rheumatology private practices: II. Second line drugs and prednisone.
    Pincus T; Marcum SB; Callahan LF
    J Rheumatol; 1992 Dec; 19(12):1885-94. PubMed ID: 1294735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Liver damage in methotrexate-treated patients. When liver biopsy is necessary in the follow-up?].
    Nieminen U; Höök-Nikanne J; Kärkkäinen P; Niemelä S
    Duodecim; 2005; 121(24):2680-8. PubMed ID: 16454249
    [No Abstract]   [Full Text] [Related]  

  • 5. [Methotrexate, liver and rheumatoid arthritis in tropical areas].
    Diouf ML; Diallo S; Mbengue M; Moreira-Diop T
    Sante; 2001; 11(3):195-200. PubMed ID: 11641084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatotoxicity of methotrexate in the treatment of psoriasis.
    Palmer HM
    Practitioner; 1973 Sep; 211(263):324-8. PubMed ID: 4759241
    [No Abstract]   [Full Text] [Related]  

  • 7. Differences in the use of second-line agents and prednisone for treatment of rheumatoid arthritis by rheumatologists and non-rheumatologists.
    Criswell LA; Such CL; Yelin EH
    J Rheumatol; 1997 Dec; 24(12):2283-90. PubMed ID: 9415629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatotoxicity associated with low-dose, long-term methotrexate treatment of rheumatoid arthritis.
    Szanto E; Sandstedt B; Kollberg B
    Scand J Rheumatol; 1987; 16(4):229-34. PubMed ID: 3629206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Slow-acting anti-rheumatic drug therapy for rheumatoid arthritis.
    Clegg DO; Ward JR
    Nurse Pract; 1987 Mar; 12(3):44, 49-52. PubMed ID: 2882451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low incidence of hepatotoxicity associated with long-term, low-dose oral methotrexate in treatment of refractory psoriasis, psoriatic arthritis, and rheumatoid arthritis. An acceptable risk/benefit ratio.
    Lanse SB; Arnold GL; Gowans JD; Kaplan MM
    Dig Dis Sci; 1985 Feb; 30(2):104-9. PubMed ID: 3967557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Massive intrahepatic hemorrhage following routine liver biopsy in a patient with rheumatoid arthritis treated with methotrexate.
    Cash JM; Swain M; Di Bisceglie AM; Wilder RL; Crofford LJ
    J Rheumatol; 1992 Sep; 19(9):1466-8. PubMed ID: 1433018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Slow acting anti-rheumatic drugs in the treatment of rheumatoid arthritis.
    Kovarsky J
    Tex Med; 1985 Sep; 81(9):35-9. PubMed ID: 3931276
    [No Abstract]   [Full Text] [Related]  

  • 13. What explains the variation among rheumatologists in their use of prednisone and second line agents for the treatment of rheumatoid arthritis?
    Criswell LA; Henke CJ
    J Rheumatol; 1995 May; 22(5):829-35. PubMed ID: 8587068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrexate Hepatotoxicity Monitoring Guidelines in Psoriasis and Rheumatoid Arthritis: Is There a Consensus?
    Clary DD; Reid AT; Kiani R; Fanciullo J
    S D Med; 2021 Aug; 74(8):363-366. PubMed ID: 34461001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Historical perspective on the use of methotrexate for the treatment of rheumatoid arthritis.
    Ward JR
    J Rheumatol Suppl; 1985 Dec; 12 Suppl 12():3-6. PubMed ID: 3913774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longterm prospective study of methotrexate in rheumatoid arthritis: conclusion after 132 months of therapy.
    Weinblatt ME; Maier AL; Fraser PA; Coblyn JS
    J Rheumatol; 1998 Feb; 25(2):238-42. PubMed ID: 9489813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatotoxicity of long-term methotrexate therapy for psoriasis.
    Tobias H; Auerbach R
    Arch Intern Med; 1973 Sep; 132(3):391-6. PubMed ID: 4783020
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatotoxicity of methotrexate in rheumatic diseases.
    Kevat S; Ahern M; Hall P
    Med Toxicol Adverse Drug Exp; 1988; 3(3):197-208. PubMed ID: 3041245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate and the liver.
    Tolman KG; Clegg DO; Lee RG; Ward JR
    J Rheumatol Suppl; 1985 Dec; 12 Suppl 12():29-34. PubMed ID: 3831362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose methotrexate therapy and hepatotoxicity. The view of the hepatologist.
    Watson RG; Smallwood RA
    Med J Aust; 1991 Oct; 155(7):428-30. PubMed ID: 1921807
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.